The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Oncology & Cancer

Fecal transplant turns cancer immunotherapy non-responders into responders
Basic & Discovery Research

Fecal transplant turns cancer immunotherapy non-responders into responders

FEB 10, 2021
Da Volterra Receives first Authorizations from Regulatory Authorities in EU Countries to Initiate Phase 3 Clinical Trial Evaluating Microbiome Protector DAV132
Clinical & Manufacturing

Da Volterra Receives first Authorizations from Regulatory Authorities in EU Countries to Initiate Phase 3 Clinical Trial Evaluating Microbiome Protector DAV132

FEB 3, 2021
Persephone Biosciences Initiates the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Response
Oncology & Cancer

Persephone Biosciences Initiates the ARGONAUT Study of Gut Microbiome-Linked Immune Modulation in Cancer Treatment Response

NOV 23, 2020
Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program
Finance

Biomica Announces Initiation of Large-Scale Production of Live Bacterial Product (LBP) Candidate Consortium in its Immuno-Oncology Program

OCT 14, 2020
Micronoma Launches with $3 Million Seed Funding
Finance

Micronoma Launches with $3 Million Seed Funding

AUG 19, 2020
A common gut microbe secretes a carcinogen
Basic & Discovery Research

A common gut microbe secretes a carcinogen

APR 4, 2020
Decoding the microbiome for clinical success – Can we increase cancer immunotherapy response rate by exploring metagenomes?
Editor's Choice

Decoding the microbiome for clinical success – Can we increase cancer immunotherapy response rate by exploring metagenomes?

JAN 23, 2020
Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions
Basic & Discovery Research

Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions

JAN 15, 2020
4D Pharma Announces Opening of a Study Investigating MRx0518 in Combination with Radiotherapy in Patients with Resectable Pancreatic Cancer
Oncology & Cancer

4D Pharma Announces Opening of a Study Investigating MRx0518 in Combination with Radiotherapy in Patients with Resectable Pancreatic Cancer

JAN 6, 2020
Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test
Oncology & Cancer

Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test

DEC 17, 2019
Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program
Oncology & Cancer

Biomica Reports Positive Preliminary Results in Animal Studies in Its Immuno-oncology Program

NOV 12, 2019